Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Xgboost profiling of quantitative lymph-node and symptom signatures distinguishes idiopathic multicentric castleman disease and its clinical subtypes

Joseph Zinski, Larissa Borys, Michael Gonzalez, David Fajgenbaum

Blood (2025) 146 (Supplement 1): 1234.

https://doi.org/10.1182/blood-2025-1234

Published: 2025

Journal Articles

Comparable response rates to therapies in idiopathic multicentric castleman disease patients with and without expert-confirmed diagnoses

Larissa Borys, Bridget Austin, Mary Jo Lechowicz, Sheila Pierson, Kayla McHugh, Abiola Irvine, Kelley Dacus, Adam Bagg, Daisy Alapat, Amy Chadburn, Megan Lim, Gordan Srkalovic, Frits van Rhee, Joshua Brandstadter, David Fajgenbaum

Blood (2025) 146 (Supplement 1): 6569.

https://doi.org/10.1182/blood-2025-6569

Published: 2025

Journal Articles

Idiopathic multicentric castleman disease unresponsive to one IL-6 inhibitor may respond to another IL-6 inhibitor

Kayla McHugh, Yuan Huang, Bridget Austin, Larissa Borys, Abiola Irvine, Daisy Alapat, Adam Bagg, Amy Chadburn, Mary Jo Lechowicz, Megan Lim, Gordan Srkalovic, Frits van Rhee, David Fajgenbaum, Lu Zhang, Joshua Brandstadter

Blood (2025) 146 (Supplement 1): 1228.

https://doi.org/10.1182/blood-2025-1228

Published: 2025

Journal Articles

Pediatric idiopathic multicentric castleman disease is often severe and responds to siltuximab

Bridget Austin, Saishravan Shyamsundar, Mateo Sarmiento Bustamante, Sheila Pierson, Larissa Borys, Kayla McHugh, Abiola Irvine, Kelley Dacus, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan Lim, Gordan Srkalovic, Frits van Rhee, Joshua Brandstadter, David Fajgenbaum

Blood (2025) 146 (Supplement 1): 3009.

https://doi.org/10.1182/blood-2025-3009

Published: 2025